Amgen

How can Teva's migraine drug face off Amgen and Lilly? Put neurologists first, DTC last, executive says
Fierce Pharma
Tue, 05/14/19 - 04:55 pm
Teva Pharmaceutical
migraines
Ajovy
Amgen
Eli Lilly
Emgality
Aimovig
neurologists
physicians
DTC advertising
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Yahoo/Benzinga
Sat, 05/11/19 - 12:31 pm
biotech
Achillion
Sesen Bio
The Medicines Company
Amgen
Daiichi Sankyo
earnings
Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions
Yahoo/Reuters
Sat, 05/11/19 - 12:10 pm
Eli Lilly
Amgen
Teva Pharmaceutical
migraines
Emgality
Aimovig
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
Xconomy
Sat, 05/4/19 - 04:54 pm
migraines
CGRP blockers
Aimovig
Amgen
Ajovy
Teva Pharmaceutical
Emgality
Eli Lilly
Amgen, Syapse enter precision medicine collaboration in oncology
Pharmaceutical Business Review
Fri, 05/3/19 - 10:46 am
Amgen
Syapse
precision medicine
oncology
cancer
Faint hope for Alder as Teva bucks dismal migraine trend
EP Vantage
Thu, 05/2/19 - 11:12 am
migraines
Alder Biopharmaceuticals
Teva
Eli Lilly
Amgen
Emgality
Ajovy
eptinezumab
Key drugs Repatha, Aimovig flail as cheap copies eat into Amgen sales
Fierce Pharma
Tue, 04/30/19 - 08:52 pm
Amgen
earnings
FDA Approves 19th Biosimilar, 2nd for Enbrel
RAPS.org
Fri, 04/26/19 - 07:38 pm
FDA
Samsung Bioepis
Eticovo
biosimilars
Amgen
Enbrel
AstraZeneca dumps Amgen-partnered drug after midphase fail
Fierce Biotech
Fri, 04/26/19 - 11:46 am
AstraZeneca
Amgen
prezalumab
Sjöogren’s syndrome
Feds say Astellas, Amgen will fork over $125M to settle charity kickback probes
Fierce Pharma
Thu, 04/25/19 - 06:49 pm
Astellas
Amgen
kickbacks
charity
DOJ
Pharma lobbyists flood the zone in D.C., with Pfizer and Amgen leading the way
Fierce Pharma
Wed, 04/24/19 - 10:47 pm
Pfizer
Amgen
lobbyists
drug pricing
competition
Consumer watchdog petitions FDA for black box warning on Amgen's Prolia
Fierce Pharma
Fri, 04/19/19 - 06:14 pm
FDA
osteoporosis
Amgen
Prolia
spinal fractures
Public Citizen
Amgen prices bone builder Evenity at $21,900/year to compete on convenience, not cost
Endpoints
Tue, 04/16/19 - 09:50 am
Amgen
osteoporosis
Evenity
drug pricing
Upcoming events – a legal verdict for Enbrel and a clinical one for Cymabay
EP Vantage
Sat, 04/13/19 - 12:23 pm
Amgen
Enbrel
CymaBay
NASH
Erelzi
seladelpar
Genfit
FDA approves Evenity for osteoporosis
BioCentury
Tue, 04/9/19 - 07:03 pm
FDA
Evenity
romosozumab
Amgen
UCB Pharma
osteoporosis
With biosims closing in, Amgen CEO Bradway scored 10% raise to $18.6M in 2018
Fierce Pharma
Tue, 04/9/19 - 06:54 pm
Amgen
Bob Bradway
executive pay
Scotland backs Aimovig for migraine after NICE says no
Pharmaforum
Tue, 04/9/19 - 08:20 am
Scotland
NICE
migraines
Aimovig
Amgen
Novartis
The top 15 pharma companies by 2018 revenue
Fierce Pharma
Mon, 04/8/19 - 11:30 pm
JNJ
Roche
Pfizer
Novartis
Merck
GSK
Sanofi
AbbVie
Bayer
Eli Lilly
Amgen
Bristol-Myers Squibb
Gilead Sciences
Teva Pharmaceutical
AstraZeneca
Coherus' Neulasta biosimilar surprises with strong early uptake
Biopharma Dive
Mon, 04/8/19 - 05:44 pm
Coherus Biosciences
Neulasta
biosimilars
Udenyca
Amgen
Lawsuit over migraine deal could be good for Amgen, analysts say
Marketwatch
Sat, 04/6/19 - 02:09 pm
Novartis
Amgen
migraines
Aimovig

Pages